Mayo Clinic, U.S.
A variety of liver cancer activities are blocked by sulfatase 1 enzyme
Published in Cancer Law Weekly, August 12th, 2006
According to recent research from the United States, "Hepatocellular carcinoma (HCC) is the third most common cause of cancer death worldwide. Improved treatments for advanced HCC are urgently needed."
"The recently identified human SULF1 desulfates cell surface heparan sulfate glycosaminoglycans and down-regulates cell growth signaling in HCC cells in vitro. While investigating the epigenetic regulation of SULF1, we discovered that histone H4 acetylation is up-regulated by SULF1 in HCC cells," said J.P. Lai and colleagues, Mayo Clinic.
Researchers...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Law Weekly
Source: Cancer Law Weekly (2006-08-12)
More Articles from Cancer Law Weekly
- Cell Press
Abnormal stimulation of a cellular trigger causes tumor-like growths in mice - Charing Cross Hospital, London, U.K.
A mutation is associated with mild clinical features in spindle cell melanoma - DUSA Pharmaceuticals
DUSA Pharmaceuticals sues additional physicians and a chemical supplier for patent infringement - G. Gaslini Children's Hospital, Genoa, Italy
Helicobacter pylori cause of gastrointestinal disease in children with hemato-oncologic disease - LQ
Market for counterfeit drugs continues increasing - Aarhus University, Denmark
Bladder cancer prognosis is associated with HER3 and HER4 expression - More from this issue of Cancer Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
